Search Results
244 results found for "Tectonic Therapeutic"
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the...
Our results suggest that GPR15/GPR15L have a pathogenic role in RA and their antagonizing could be a therapeutic
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Pc(4-4) may become a promising candidate for future therapeutic cancer treatment."
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
discrete and separable effects and provide proof of concept for the development of safer GPCR-targeting therapeutics
- HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural ...
Overall, our work reveals insight into PI3Kγ regulation and identifies sites that may be exploited for therapeutic
- TLR4 biased small molecule modulators
Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
and stabilizing IGF1R, and suggests that it may serve as a valuable prognostic factor and potential therapeutic
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
particularly aggressive and heterogeneous disease with few effective targeted therapies and precision therapeutic
- Canonical chemokine receptors as scavenging “decoys”
The scavenging function of CKRs should be considered when evaluating the safety and therapeutic efficacy
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
the current status of ligand development targeting LPA receptors to modulate LPA signaling and their therapeutic
- 📰 GPCR Weekly News, June 10 to 16, 2024
synaptic depression in dorsolateral striatum of adult male mice Methods & Updates in GPCR Research RNA therapeutics
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
indicated by the fact that about 40% of all drugs currently used in clinical practice mediate their therapeutic
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic
- Do You Believe AI Could Accelerate Drug Discovery?
challenges is crucial to fully harness AI's potential in accelerating drug discovery and optimizing therapeutic
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
puzzles and underscores the importance of understanding cellular processes at the molecular level for therapeutic
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
cognate positions across GPCR paralogs opens a window into cancer mechanisms and potential approaches to therapeutics
- 📰 GPCR Weekly News, October 9 to 15, 2023
Tethered Ligands that Target the µ-Opioid Receptor Design and Synthesis of Novel GPR139 Agonists with Therapeutic
- 📰 GPCR Weekly News, May 15 to 21, 2023
Hopkins, Exscientia’s founder and CEO was elected a Fellow of the Academy of Medical Sciences Structure Therapeutics
- 📰 GPCR Weekly News - January 2 to 8, 2023
Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics
- Interacting binding insights and conformational consequences of the differential activity of...
way for understanding the CBD pharmacology at a molecular level and aid in harnessing its potential therapeutic
- 📰 GPCR Weekly News, March 18 to 24, 2024
Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
understanding how serotonin receptors, one of the largest subfamilies of class A GPCRs and potential therapeutic
- Dr. GPCR University registration is now open! Secure your spot now!
the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics
- Exploring the Breakthroughs in GPCR Research
GPCRs remain one of the most prolific and fertile therapeutic drug targets.
- 📰 GPCR Weekly News, January 23 to 29, 2023
Orbit Discovery and Endevica Bio enter multi-target collaboration to advance development of cachexia therapeutics
- 📰 GPCR Weekly News, October 16 to 22, 2023
potential use of Opn5 and its homologs Industry News The Leading GPCR Company in Immuno-Oncology, Domain Therapeutics
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively activate therapeutically analyzing drug-target interactions and disease pathways, AI can identify potential candidates that may have therapeutic
- 📰 GPCR Weekly News - January 9 to 15, 2023
Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research collaborations GPCR Therapeutics